Antioxidant-delivery nanosystems lipid nanocarriers oxidative stress ROS neuroinflammation neurodegeneration neurological long COVID-19
SHSY-5Y cells
Nanocarriers
Ginkgo biloba bioactive compounds
Amyotrophic lateral sclerosis
Drug delivery
Endoplasmic reticulum stress
Neuroinvasive coronavirus infection
Antioxidant-delivery nanosystems
Neurodegenerative diseases
Nanomedicine
Antioxidant
Cubosomes
Parkinson's disease
SAXS Cryo-TEM
Nanofibers
Nanoparticle therapeutic efficacy
Cubosome
Anti-inflammatory and anti-apoptotic agents
Solid lipid nanoparticles
Nanomedicine for growth factor delivery
Neuroprotective assemblies
Pituitary adenylate cyclase-activating polypeptide PACAP
Blood-brain barrier
Cell-penetrating peptide CPP
Neuroprotection
Lipid nanoparticles liquid crystalline nanocarriers cubosomes cell-penetrating peptide CPP CPP-functionalized particles pituitary adenylate cyclase-activating polypeptide PACAP neuroprotection nanomedicine
Biotherapeutics
Liquid crystalline nanocarriers
Curcumin amphiphilic nanoparticles self-assembled nanoparticles solid lipid nanoparticles liposomes liquid crystalline carriers nanomedicine drug delivery neurodegenerative diseases Alzheimer's disease Parkinson's disease Huntington disease amyotrophic lateral sclerosis oxidative stress neuroprotection antioxidant blood-brain barrier SHSY-5Y cells
Alzheimer's disease
Nanotherapy
Neurodegeneration
CPP-functionalized particles
Liposomes
Lipid nanoparticles
ROS
Liquid crystalline carriers
Amphiphilic nanoparticles
Tunicamycin
Brain-derived neurotrophic factor BDNF
Lipid liquid crystalline nanoparticles
Huntington disease
Oxidative stress
Lipid nanocarriers
Neurological long COVID-19
Spongosome
In vivo and in vitro models
Self-assembled nanoparticles
Curcumin
Neuroinflammation
Neurological long COVID